Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Merchante, N
  • Rodriguez-Fernandez, M
  • Figueruela, B
  • Rodriguez-Arrondo, F
  • Revollo, B
  • Ibarra, S
  • Tellez, F
  • Merino, E
  • Galindo, MJ
  • Rivero-Juarez, A
  • de Los Santos, I
  • Delgado-Fernandez, M
  • Garcia-Deltoro, M
  • Vera-Mendez, FJ
  • Garcia, MA
  • Aguirrebengoa, K
  • Portu, J
  • Rios-Villegas, MJ
  • Villalobos, M
  • Aleman-Valls, MR
  • Minguez, C
  • Galera, C
  • Macias, J
  • Pineda, JA

Grupos

Abstract

Background: Previous studies have suggested that hepatocellular carcinoma (HCC) has an aggressive presentation and a shorter survival in people with HIV (PWH). This could be due to later diagnosis or lower rates of HCC treatment, and not to HIV infection itself. Aim: : To assess the impact of HIV on HCC survival in hepatitis C virus (HCV)-infected patients. Methods: Multicenter cohort study (1999-2018) of 342 and 135 HCC cases diagnosed in HIV/HCV-infected and HCV-monoinfected patients. Survival after HCC diagnosis and its predictors were assessed. Results: HCC was at Barcelona-Clinic Liver-Cancer (BCLC) stage 0/A in 114 (33%) HIV/HCV-coinfected and in 76 (56%) HCV-monoinfected individuals (P < 0.001). Of them, 97 (85%) and 50 (68%) underwent curative therapies (P = 0.001). After a median (Q1-Q3) follow-up of 11 (3-31) months, 334 (70%) patients died. Overall 1 and 3-year survival was 50 and 31% in PWH and 69 and 34% in those without HIV (P = 0.16). Among those diagnosed at BCLC stage 0/A, 1 and 3-year survival was 94 and 66% in PWH whereas it was 90 and 54% in HIV-negative patients (P = 0.006). Independent predictors of mortality were age, BCLC stage and alpha-fetoprotein levels. HIV infection was not independently associated with mortality [adjusted hazard ratio (AHR) 1.57; 95% confidence interval: 0.88-2.78;P = 0.12]. Conclusion: HIV coinfection has no impact on the survival after the diagnosis of HCC in HCV-infected patients. Although overall mortality is higher in HIV/HCV-coinfected patients, this seem to be related with lower rates of early diagnosis HCC in HIV-infected patients and not with HIV infection itself or a lower access to HCC therapy.

Datos de la publicación

ISSN/ISSNe:
0269-9370, 1473-5571

AIDS  LIPPINCOTT WILLIAMS & WILKINS

Tipo:
Article
Páginas:
1497-1507
PubMed:
32675563
Factor de Impacto:
2,195 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 9

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • cirrhosis; hepatitis C virus; hepatocellular carcinoma; HIV; liver cancer

Compartir